Evexia Lifecare Limited received a disclosure from Shree Saibaba Exim Private Limited, a member of the promoter group, regarding the purchase of 50,33,131 equity shares on September 23, 2026. The transaction was executed through the open market on the BSE.

This acquisition increases the promoter group's holding in the company. The disclosure was made under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction details

The purchase was completed on September 23, 2026. Shree Saibaba Exim Private Limited acquired the shares via open market transactions. No derivative trading was reported in connection with this event.

What the numbers show

The purchase represents a 0.268% increase in the promoter group's stake. This incremental buying raises their total holding from 6.121% to 6.389% of the total share capital. The transaction size is significant relative to the daily trading volume typically seen for small-cap stocks, indicating a deliberate accumulation strategy by the promoter entity.

Regulatory compliance

The company filed the necessary forms with BSE Limited to record the change in shareholding. The disclosure confirms that the acquirer belongs to the promoter group and that the shares carry voting rights. There are no encumbrances or warrants associated with this specific block of shares.

Evexia Lifecare promoter group entity Shree Saibaba Exim Private Limited purchased 37,61,527 equity shares in the company on September 18, 2026. The acquisition was executed via the open market on the Bombay Stock Exchange (BSE).

The transaction raises Shree Saibaba Exim’s total holding to 11,34,67,585 shares, representing 6.037% of the company’s paid-up capital. Prior to this purchase, the entity held 10,97,06,058 shares, or 5.837% of the stake.

Regulatory Disclosures

The purchase was disclosed under Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The disclosure was submitted to the company on September 17, 2026, and subsequently filed with the BSE on September 18, 2026.

Additionally, the transaction triggered a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the acquirer belongs to the promoter group and that the mode of acquisition was through the open market.

Holding Details

The total equity share capital of Evexia Lifecare remains at 18,77,32,895 shares, with a face value of Re. 1 each. There were no changes in voting rights otherwise than by shares, nor any acquisition of warrants or convertible securities.